Cadinha & Co. LLC Lowers Stock Holdings in The Clorox Company (NYSE:CLX)

Cadinha & Co. LLC lessened its stake in shares of The Clorox Company (NYSE:CLX) by 7.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,500 shares of the company’s stock after selling 200 shares during the period. Cadinha & Co. LLC’s holdings in Clorox were worth $406,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Brooklyn Investment Group raised its position in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC purchased a new stake in Clorox in the third quarter worth about $27,000. Continuum Advisory LLC lifted its stake in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the period. Quarry LP increased its position in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Clorox in the 3rd quarter valued at about $48,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.1 %

Shares of Clorox stock opened at $160.31 on Friday. The firm’s 50 day simple moving average is $164.25 and its two-hundred day simple moving average is $156.38. The firm has a market capitalization of $19.84 billion, a price-to-earnings ratio of 55.86, a PEG ratio of 2.90 and a beta of 0.42. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm earned $0.49 EPS. The firm’s revenue was up 27.0% on a year-over-year basis. Analysts predict that The Clorox Company will post 6.87 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.04%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 170.04%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. JPMorgan Chase & Co. boosted their price target on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research report on Thursday. Barclays dropped their price objective on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research report on Friday. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $156.54.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.